Y.Lebrn-MiladK.MiladM
Patients should be counseled on expected timelines
Glutathione plays a variety of roles in the body, including: regenerating other antioxidants (e.g., vitamin C, vitamin E) neutralizing free radicals detoxification of certain drugs regulating the immune system managing inflammation supporting various bodily systems (e.g., nervous system, pulmonary system) delaying cell aging Glutathione depletion is also linked to numerous health issues, including increased susceptibility to infectious diseases and illnesses, oxidative stress, and certain chronic diseases, such as type 2 diabetes, certain types of cancer, kidney disease, neurodegenerative disease, liver disease, and cardiovascular disease ( 1 , 2 )
That story took me to two individuals who had experimented with lowdose topical and subcutaneous GHKCu for months
[sources 16] SLC1A1 is excitatory amino acid transporter 3 (EAAT3), a glutamate transporter located in neurons, SLC22A3 is an extraneuronal monoamine transporter that is present in astrocytes, and SLC22A5 is a high-affinity carnitine transporter
If you're going to use 5-Amino-1MQ beyond 12 weeks, do it with baseline labs, regular monitoring, and a clear understanding that you're working ahead of the published evidence curve